Should I buy SPX Technologies (SPXC) stock or is it too late?

SPX Technologies · Industrials · price $205

See the full SPX Technologies (SPXC) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Truist Securities — 69% of its targets hit on this sector (204 calls tested). It aims for $301 (+47 %), call made on August 4, 2026, maturing on August 4, 2027 (24 d ago).

The 3 reliable analysts $285+39 %

The 3 other firms $243+18 %

How to read it: the 3 reliable firms are not filtered by optimism — 3 aim above the price, 0 below, hence their $285 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on SPX Technologies

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Oppenheimer	100 %	+43.8 %	8	$280 +36%

In short — Should you invest in SPX Technologies? Is it too late, still worth it? Analysts are overwhelmingly positive (100% buy, median target $275, i.e. +34%), and the most reliable on SPXC targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

100% of analysts rate it a buy (Buy consensus, 6 ratings) — a sign of market conviction.
Median price target $275, i.e. +34% from the current price ($205).
The most reliable firm on SPXC, Oppenheimer (100% hit rate, 8 scored calls), targets $280 (call made on July 20, 2026, maturing on July 20, 2027) (+36%) in its most recent call, and $272 (call made on February 25, 2026, maturing on February 25, 2027) (+33%) in the one coming due soonest.

⚠️ Reasons to hesitate

A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.
A near-unanimous consensus leaves little room for positive surprise — a lot of optimism is already baked in.

The analyst consensus on SPXC

Median target $275 (+34%) · 6 ratings · Buy consensus

Strong Buy00%

Buy6100%

Hold00%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in SPX Technologies now?

We won't decide for you. The facts: 100% of analysts rate it a buy, median target $275 (+34%), and Oppenheimer (most reliable on SPXC, 100%) targets $280. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in SPX Technologies?

Not according to analysts: the median target ($275) is still +34% above the current price ($205) (most reliable on SPXC: Oppenheimer, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is SPX Technologies still worth investing in?

It depends on the gap between the price ($205) and its estimated value: analysts target $275 on median (+34%), with 100% buys (most reliable on SPXC: Oppenheimer, 100%). Cross-check with their real reliability on SPXC and the cautions above. Information, not advice.

What's the main risk in buying SPXC?

A 12-month target is not a guaranteed path: the price can fall in the meantime.

→ Go deeper: the full SPX Technologies profile (consensus, analyst reliability, price target, performance).